Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

July 8, 2011

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

July 5, 2011

High folate intake may reduce risk of colorectal cancer
Intake of high levels of folate may reduce colorectal cancer risk, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. Folate is a water-soluble B vitamin that occurs naturally in food.
Read article at medicalxpress.com

June 30, 2011

Researchers find herbal medicine treatment reduces inflammation in allergen-induced asthma
Researchers from Boston University School of Medicine (BUSM) using a traditional Korean medicine, SO-CHEONG-RYONG-TANG (SCRT) that has long been used for the treatment of allergic diseases in Asia, found that SCRT treatment alleviates asthma-like pulmonary inflammation via suppression of specific chemokines or proteins.
Read article at medicalxpress.com

June 29, 2011

Vitamin E tocotrienols show cholesterol benefits for healthy adults: Study
Vitamin E tocotrienol-rich supplements may improve blood cholesterol levels and reduce the risk of heart disease, especially in people over 50, says a new study from Malaysia.
Read article at nutraingredients-usa.com

June 27, 2011

Combination of calcium, vitamin D reduces melanoma risks in some women
A combination of calcium and vitamin D may cut the chance of melanoma in half for some women at high risk of developing this life-threatening skin cancer, according to a new study by Stanford University School of Medicine researchers.
Read article at medicalxpress.com

For more natural health news, click here.

See also our 2001-2010 news archive, by clicking here.

Pharma "Business with Disease" News

July 5, 2011

Antidepressant Use During Pregnancy Linked to Higher Risk of Autism
Children whose mothers use antidepressants during pregnancy may be more likely to develop autism than kids whose mothers do not, say researchers in California. In a study involving data on more than 1,800 children — fewer than 300 of whom had an autism spectrum disorder (ASD) — and their mothers, the scientists found that women who were prescribed drugs to treat depression in the year before giving birth were twice as likely to have children with an ASD, compared with women who did not take antidepressants.
Read article on the Time Magazine website (USA)

July 4, 2011

Ibuprofen and aspirin linked to irregular heart rhythm
Commonly used painkillers including ibuprofen increase the risk of developing an irregular heart rhythm by up to 40 per cent, according to a new study.
Read article in the Daily Telegraph (UK)

July 4, 2011

Heart concerns raised about anti-smoking drug Champix
A popular smoking-cessation medication may be linked to an increased risk of cardiovascular problems, a new study has found, adding to questions about the drug’s safety.
Read article in The Globe and Mail (Canada)

July 2, 2011

Harvard Docs Disciplined For Conflicts Of Interest
Three years after they were fingered in a US Senate probe into the interplay between academics who receive grant money from both pharma and the National Institutes of Health, three prominent psychiatrists from Harvard Medical School and Massachusetts General Hospital have been sanctioned for violating conflict of interest rules and failing to report the extent of their payments.
Read article at pharmalot.com

June 30, 2011

Fetal Exposure to Common Epilepsy Drugs May Harm Kids' IQ: FDA
The U.S. Food and Drug Administration on Thursday advised doctors to warn women of childbearing age that fetal exposure to certain drugs used to control seizures or migraines appears to diminish intellectual abilities in offspring. The drugs include so-called "valproate products" -- medications such as valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, Depakote ER), valproic acid (Depakene, Stavzor), and their equivalent generic formulations, the FDA said in a statement.
Read article on the US News and World Report website

June 27, 2011

France Decides Sanofi’s Multaq Is ‘Insufficient’
Once again, Sanofi is facing trouble with Multaq. The latest difficulty comes from French regulators that have reevaluated the effectiveness of the drug, which is used to treat atrial fibrillation, after two patients developed severe liver damage. The move comes just nine months after Multaq, which was once seen as a salve for the drugmaker, was launched in France.
Read article at pharmalot.com
Comment: Last year, a new analysis of adverse event reports indicated Multaq may cause or worsen heart failure, trigger potentially lethal irregular heartbeats and impair kidney function. Significantly, therefore, questions have been raised about the study that was used by the drugmaker in its submission for US FDA approval (see here and here).

June 27, 2011

A Neurontin Study Was Really A Seeding Trial
A 1995 study that was ostensibly designed to assess the safety, efficacy, tolerability and quality of life among Neurontin patients was actually a thinly disguised seeding trial, according to an article in The Archives of Internal Medicine. The finding is one of the rare instances in which evidence of a seeding trial - an industry term for a study designed for marketing purposes - has been uncovered. The last example involved a study for the Vioxx painkiller that was withdrawn by Merck (see this).
Read article at pharmalot.com

June 26, 2011

Diabetes Drug From Bristol Linked To Certain Cancer Types
An experimental diabetes drug from Bristol-Myers Squibb known as dapagliflozin has been found to be linked to certain types of cancers.
Read article at smartabouthealth.net

June 24, 2011

Takeda's Actos, Glaxo's Avandia Raise Risk of Eye Disease
Takeda Pharmaceutical Co.'s Actos, the world's best-selling diabetes treatment, and GlaxoSmithKline Plc.'s Avandia raise the risk of an eye disease that can lead to blindness, a study shows. People taking the drugs have a 3 to 6 times increased risk of developing diabetic macular edema, a condition in which the retina thickens and swells, according to a study of more than 100,000 people to be presented Sunday at the American Diabetes Association's annual meeting in San Diego.
Read article in the San Francisco Chronicle (USA)

For more pharma "business with disease" news, click here.

See also our 2001-2010 news archive, by clicking here.

GMO News

July 5, 2011

EU lawmakers give backing for national GM crop bans
European Union lawmakers voted on Tuesday to strengthen proposals to let governments decide whether to grow or ban genetically modified (GM) crops, designed to break a deadlock in EU GM crop approvals. Despite the majority backing of the European Parliament for the plans, continued opposition from several large EU member states means the draft legislation is unlikely to be finalized this year, if at all. EU lawmakers agreed that governments should be free to ban the cultivation of GM crops based on environmental concerns, such as to protect biodiversity or prevent the spread of "super weeds" that are resistant to herbicides.
Read news report at reuters.com

For more GMO news, click here.

See also our 2001-2010 news archive, by clicking here.

Other Health-related News

July 6, 2011

Pregnant women 'not taking enough' vitamin D
Pregnant women in Ireland have vitamin D intakes far below those recommended for the normal development of a child’s bones, according to a new study. The research, published in the latest issue of the European Journal of Clinical Nutrition, found the average dietary intake of vitamin D among pregnant women in Ireland was 80 per cent below the Food Safety Authority’s recommendation for an average adult.
Read article in The Irish Times (Ireland)
Comment: Recent research has shown that even high levels of vitamin D supplementation in pregnant women can safely and effectively raise circulating levels of this nutrient to optimal levels, with no adverse effects to either women or their newborns.

July 4, 2011

Norway: No high-dose omega-3 adverse effects
Norwegian authorities have conducted a safety review of omega-3 forms EPA and DHA and found no adverse effects up to levels as high as 6.9g per day for certain conditions – a level far in excess of recent German recommendations of 1.5g/day. The Norwegian Scientific Committee for Food Safety (VKM) surveyed dosage levels and effects for a host of conditions including bleeding times; lipid peroxidation; inflammation and immunity; glucose metabolism and gastrointestinal disturbances. After surveying the literature, they found that adverse effects were not present below 6.9g for bleeding times and concluded: "no tolerable upper intake level could be established."
Read article at nutraingredients.com

June 27, 2011

ANH: Herbal Medicinal Products Directive is “a protectionist tool”
The Alliance for Natural Health International has slammed the European Commission’s Traditional Herbal Medicinal Products Directive as “a protectionist tool.” In an open letter to European commissioner John Dalli, Robert Verkerk, the alliance’s founder and scientific director wrote: “It seems that the criticism you now face in some quarters is down to the creation by the EU of what is effectively a protectionist tool; one which favours certain products of the European phytopharmaceutical system and discriminates against those of non-European traditional systems of medicine.”
Read article at nutraingredients.com

June 25, 2011

Diabetes explosion leads to 350 million suffering from disease worldwide
Rates of diabetes have exploded in the past three decades with an estimated 350 million people in the world now suffering from the disease, according to new research. Almost every region of the planet has seen a rise in diabetes prevalence or has failed to reduce levels of the disease, a major international study has revealed. The condition, which is the result of poorly controlled sugar levels in the blood, can lead to serious compliations such as damage to the kidneys, blindness, nerve damage, heart disease and limb loss. Each year, high blood sugar levels and diabetes kill three million people worldwide.
Read article in the Daily Telegraph (UK)
Comment: Cellular Health research has shown that diabetes can be eradicated naturally. To read Dr. Rath's Cellular Health recommendations for this health problem, click here to download chapter 7 of his classic book, "Why Animals Don't Get Heart Attacks … But People Do!" To read independent scientific publications showing how an optimum intake of vitamins and other micronutrients can help prevent diabetes and correct existing diabetic conditions and complications, click here.

For more health-related news, click here.

See also our 2001-2010 news archive, by clicking here.

Political News

June 16, 2011

Bilderberg 2011: The Rockefeller World Order and the "High Priests of Globalization"
Investigative journalist Daniel Estulin’s report of inside sources in this year’s meeting indicated a rather extensive discussion on the role of China, which is hardly surprising, considering this has been a central topic of discussion in meetings for a number of years. China emerged in discussions on Pakistan, as China has become increasingly Pakistan’s closest economic and strategic ally, a trend that is continuing as America continues to spread the Afghan war into neighbouring Pakistan. China is also a major player in Africa, threatening the West’s stranglehold over the continent, in particular through the World Bank and IMF. Most importantly, however, and not unrelated to its role in Pakistan and Africa, China has become the greatest economic competitor for the United States in the world, and as the IMF even admitted recently, its economy is expected to surpass that of the United States by 2016. Bilderberg paid attention to this issue not simply as a financial-economic consideration, but as a massive geopolitical transition in the world: “the biggest story of our time.”
Read article on the Centre for Research on Globalization website

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website. Citizens of the UK can find additional UK-orientated news stories on the Reject the EU website.

 

Back to the Newsletter Archive…